New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major advancement in image-guided navigation for prostate cancer care with ...
SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through ...
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...
Seven years after the activation of the prostate biopsy service using Fusion technology, one of the most advanced innovations internationally for combating prostate cancer, the 'San ...
Ernie Strauss and Ronald Wakefield, who met through the patient navigation program of Northside Hospital, have built a ...
Research from the University of Cambridge may be able to start a national screening programme for the common cancer ...
Prostate cancer is the second most commonly diagnosed cancer in men globally, according to the World Health Organisation (WHO ...
“For localised prostate cancer, treatment options include surgery or radiotherapy. Both give equivalent cure rates,” Dr Komen ...
Supporting prostate cancer diagnosis with more precise guidance for clinicians, offering better patient care Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results